<DOC>
	<DOCNO>NCT00506233</DOCNO>
	<brief_summary>Primary Objective : 1 . To determine feasibility conduct multi-site longitudinal observational study patient chronic graft-versus-host disease ( GVHD ) .</brief_summary>
	<brief_title>Feasibility Study Collecting Multicenter Chronic GVHD Data</brief_title>
	<detailed_description>If agree take part study , ask fill-out questionnaire , medical record review . Your doctor healthcare provider also ask complete questionnaire . You ask fill-out questionnaire 3 different time ( join study , 3 month later , 6 month later ) . The questionnaire include question chronic GvHD impact body , day-to-day activity , emotion perception , social sexual life . Each questionnaire 195 question . Each take 20-30 minute complete , also ask long take complete questionnaire . For participant , visit part routine schedule follow-up disease . You several option may choose complete questionnaire . They may complete visit doctor appointment , home ( mail back self-addressed stamp envelope provide ) , internet . If interested internet option , please ask study staff detail . If time , healthcare provider think would best interest receive survey one schedule time point , give survey time , take study . Your healthcare provider ask fill-out questionnaire ask found physical exam routine laboratory test , medication take , severe chronic GvHD clinic visit . Your medical record review 1 year enrollment study collect information stem cell transplant procedure , medication , medical condition , result test procedure . The review medical record require active participation . You study complete 6-month questionnaire . This investigational study . There cost involve participation study . Up 40 participant take part multicenter study . Up 15 enrol M. D. Anderson .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>1 . Age great equal 2 year 2 . Prior allogeneic stem cell transplant , graft source , donor type , GVHD prophylaxis allow 3 . If prevalent case ( define enrollment three month chronic GVHD diagnosis ) , subject must within 2 year stem cell infusion 4 . Diagnosis chronic GVHD meeting diagnostic criterion diagnosis stag group NIH consensus conference 5 . Need systemic treatment , define medication intervention deliver systemically , include extracorporeal photopheresis . If patient receive topical local therapy diagnosis , subsequently require systemic treatment , may enrol upon initiation systemic therapy . ( Note , patient classify incident prevalent case depend time chronic GVHD diagnosis , start systemic therapy ) 6 . Progressionfree malignancy enrollment ( evidence primary disease progression since transplant , although residual disease may still present ) 7 . Evaluation transplant center time study enrollment , agreement reevaluate transplant center 3 6 month 8 . Signed , inform consent applicable , child assent 1 . Inability verbally communicate English 2 . Inability comply study procedures 3 . Anticipated survival le 6 month due comorbid disease persistent malignancy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Graft-Versus-Host Disease</keyword>
	<keyword>GVHD</keyword>
	<keyword>Questionnaire</keyword>
</DOC>